Free Trial

Y-mAbs Therapeutics (YMAB) SEC Filings & 10K Form

Y-mAbs Therapeutics logo
$4.41 +0.30 (+7.30%)
Closing price 05/2/2025 04:00 PM Eastern
Extended Trading
$4.41 0.00 (0.00%)
As of 05/2/2025 05:17 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Y-mAbs Therapeutics SEC Filings

DateFilerForm TypeView
04/28/2025
7:14 PM
Y-mAbs Therapeutics (Filer)
Form 10-K/A
03/11/2025
7:15 PM
Gad Thomas (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
7:17 PM
Rossi Michael J (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
3:32 PM
Gad Thomas (Reporting)
Y-mAbs Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/07/2025
3:36 PM
Smith Susan Laura (Reporting)
Y-mAbs Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/07/2025
3:40 PM
Rajah Vignesh (Reporting)
Y-mAbs Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/07/2025
3:26 PM
Rossi Michael J (Reporting)
Y-mAbs Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2025
6:48 AM
Y-mAbs Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/04/2025
6:15 AM
Y-mAbs Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2025
6:24 AM
Y-mAbs Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
01/22/2025
5:57 PM
LaRocca John (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
6:00 PM
Rossi Michael J (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
6:01 PM
Wilms Joris (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
6:03 PM
Gentilcore Douglas J (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
6:04 PM
Gad Thomas (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
6:05 PM
PFREUNDSCHUH PETER P. (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2025
3:44 PM
LaRocca John (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/13/2025
8:21 AM
Y-mAbs Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2025
8:27 AM
Y-mAbs Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
3:32 PM
Paradigm Biocapital Advisors LP (Filed by)
Y-mAbs Therapeutics (Subject)
Form SC 13G/A
11/08/2024
6:18 AM
Y-mAbs Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/08/2024
5:55 AM
Y-mAbs Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2024
1:16 PM
VANGUARD GROUP INC (Filed by)
Y-mAbs Therapeutics (Subject)
Form SC 13G/A
11/04/2024
7:51 AM
Y-mAbs Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/17/2024
7:05 PM
Gad Thomas (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
4:24 PM
Y-mAbs Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/13/2024
3:19 PM
Gad Thomas (Reporting)
Y-mAbs Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/12/2024
6:06 AM
Y-mAbs Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/12/2024
5:50 AM
Y-mAbs Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/19/2024
3:15 PM
Y-mAbs Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/12/2024
4:29 PM
PFREUNDSCHUH PETER P. (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2024
6:59 PM
PFREUNDSCHUH PETER P. (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/01/2024
3:20 PM
Y-mAbs Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2024
8:00 PM
TYAGI ASHU (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
8:00 PM
GILL DAVID N (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
8:01 PM
HEALY JAMES (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
8:01 PM
Wedell-Wedellsborg Johan (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
8:02 PM
Hamill Laura (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
8:02 PM
TAGLIAFERRI MARY (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
3:05 PM
Y-mAbs Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2024
6:53 PM
Gad Thomas (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Elon Set to Shock the World by May 1st ? (Ad)

Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believes will be Elon’s greatest invention ever… Yes, even bigger than Tesla or SpaceX.

Click here now because after June 1st, it could be too late.
06/11/2024
6:54 PM
Ber Gerard (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
3:44 PM
Gad Thomas (Reporting)
Y-mAbs Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/31/2024
8:36 PM
Kruse Bo (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
5:54 PM
Gad Thomas (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
3:42 PM
Gad Thomas (Reporting)
Y-mAbs Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:YMAB) was last updated on 5/3/2025 by MarketBeat.com Staff
From Our Partners